nephrin Inhibitors

Common nephrin Inhibitors include, but are not limited to MLR-1023 CAS 41964-07-2, GSK2656157 CAS 1337532-29-2, MLR-1023 CAS 41964-07-2, GSK2656157 CAS 1337532-29-2 and MLR-1023 CAS 41964-07-2.

Nephrin inhibitors belong to a distinct chemical class of compounds that target the nephrin protein, a crucial component of the glomerular filtration barrier in the kidney. Nephrin is a transmembrane protein expressed in podocytes, specialized cells that constitute a critical part of the kidney's glomeruli. The glomerular filtration barrier acts as a selective sieve, allowing essential substances to be filtered from the blood into the urine while preventing the loss of vital proteins and blood cells. Nephrin plays a pivotal role in maintaining the integrity and function of the glomerular filtration barrier. It forms a complex network of intercellular junctions, called slit diaphragms, between adjacent podocytes. This complex structure restricts the passage of macromolecules, ensuring the preservation of essential proteins in the blood while allowing waste products to be excreted in the urine.

Nephrin inhibitors are designed to selectively interact with nephrin, modulating its function and disrupting the integrity of the slit diaphragms. By inhibiting nephrin, these compounds may alter the permeability of the glomerular filtration barrier, affecting the kidney's filtration capacity and leading to proteinuria, a condition characterized by the presence of excessive protein in the urine. Researchers are actively studying the pharmacological properties and mechanisms of action of nephrin inhibitors to understand their impact on the structure and function of the glomerular filtration barrier. It is important to note that the current understanding of nephrin inhibitors is primarily based on research, and further investigations are necessary to elucidate their precise effects on nephrocyte function and the kidney's overall filtration process.